Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Chronic Myelogenous Leukemia].

Deutsche medizinische Wochenschrift (1946) - 1 Sept 2018

Hochhaus Andreas, Eigendorff Ekkehard, Ernst Thomas

Abstract excerpt

The advent of tyrosine kinase inhibitors (TKI) has improved prognosis and outcome of patients with chronic myelogenous leukemia (CML) considerably. In comparison to imatinib, first line use of second generation inhibitors nilotinib, dasatinib and bosutinib lead to faster and deeper molecular remissions accompanied by a novel adverse event profile. Essential part of the management of CML patients is a consequent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blast Crisis
Share to Cytogenetic Analysis
Share to Dasatinib

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Nitriles

Share to Pregnancy Complications, Hematologic

Share to Pregnancy Complications, Neoplastic

Share to Quinolines

Source

Identifiers

PMID: 30199910
DOI: 10.1055/s-0043-121023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Chronic Myelogenous Leukemia].PMID 30199910Read ↗

Chronic myelogenous leukemia.Semantic proximity Read ↗

[Myeloproliferative neoplasms (including chronic myeloid leukemia)].Semantic proximity Read ↗

Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature ReviewSemantic proximity Read ↗

[Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia].Semantic proximity Read ↗

[Acute myeloid leukemia].Semantic proximity Read ↗

[Acute myeloid leukemia].Semantic proximity Read ↗

Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemia.Semantic proximity Read ↗

[The efficacy analysis of interferon combined with imatinib in chronic myelogenous leukemia patients with ABL kinase domain mutations].Semantic proximity Read ↗

[Molecular monitoring: an essential component of the treatment for chronic myeloid leukemia].Semantic proximity Read ↗

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib TherapySemantic proximity Read ↗

Targeted Chronic Myeloid Leukemia Therapy: Seeking a CureSemantic proximity Read ↗

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.